Cover Image
Market Research Report

Global Drug-Device Combination Market 2017-2027: Drug Eluting Stents, Photosensitizers, Orthopaedic Products, Infusion Pumps, Wound Care Products, Transmucosal Products, Transdermal Patches

Published by Visiongain Ltd Product code 562115
Published Content info 151 Pages
Delivery time: 1-2 business days
Price
Back to Top
Global Drug-Device Combination Market 2017-2027: Drug Eluting Stents, Photosensitizers, Orthopaedic Products, Infusion Pumps, Wound Care Products, Transmucosal Products, Transdermal Patches
Published: August 30, 2017 Content info: 151 Pages
Description

The global drug-device combination market was valued at $137bn in 2016 and is projected to grow at a CAGR of 6.2% in the first half of the forecast period. In 2016, the market is dominated by the Transmucosal submarket which held 21% share of the drug-device combination market.

How this report will benefit you

Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 151 page report you will receive 124 charts - all unavailable elsewhere.

The 151-page report provides clear detailed insight into the global drug-device combination market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand new report today you stay better informed and ready to act.

Report Scope

  • Global Drug-Device Combination Market forecasts from 2017-2027
  • Revenue forecast for the drug-device combination market by End-Users:
    • Hospitals & clinics
    • Emergency service centers
    • Ambulatory surgical centers
    • Home care settings

Each submarket is further divided by region: North America, Europe, Asia-Pacific and Rest of the World

  • Revenue forecast for the drug-device combination market by Products:
    • Drug eluting stents
    • Photosensitizers
    • Orthopaedic products
    • Infusion pumps
    • Wound care products
    • Transmucosal products
    • Transdermal patches
    • Others

Each submarket is further divided by region: North America, Europe, Asia-Pacific and Rest of the World

  • This report provides individual revenue forecasts from 2017-2027 for these regional and national markets:
    • North America: The U.S and Rest of North America
    • Europe: France, Germany, Italy, U.K, Spain, Russia and Rest of Europe
    • Asia-Pacific: China, India, Japan, and Rest of Asia-Pacific countries
    • Rest of the world (RoW) : Latin America, and Middle East and African countries

image1

Each regional market is further divided by end-users and products

  • This report discusses the leading companies in the global drug-device combination market:
    • Medtronic
    • Boston Scientific Corporation
    • Stryker Corporation
    • Ethicon Inc
    • C.R. Bard Inc.
    • Medline Industries Inc.
    • Mylan Inc.
    • Terumo Corporation
    • Pinnacle Biologics Inc.
    • W. L. Gore & Associates, Inc.
  • This report discusses the drivers, restraints as well as porter's five forces analysis of the global drug-device combination market

Visiongain's study is intended for anyone requiring commercial analyses for the global drug-device combination market. You find data, trends and predictions.

Table of Contents
Product Code: PHA0230

Table of Contents

1. Report Overview

  • 1.1 Global Drug-Device Combination Market Overview
  • 1.2 Why You Should Read This Report
  • 1.3 Key Questions Answered by This Analytical Report
  • 1.4 Who is This Report For?
  • 1.5 Methodology
  • 1.6 Frequently Asked Questions (FAQ)
  • 1.7 Associated Visiongain Reports
  • 1.8 About Visiongain

2. Drug-Device Combination Market Definition

  • 2.1 What are Drug-Device Combination Products?
  • 2.2 Types of Drug-Device Combination Products
    • 2.2.1 Drug Eluting Stents
    • 2.2.2 Photosensitizers
    • 2.2.3 Orthopedic Products
    • 2.2.4 Infusion Pumps
    • 2.2.5 Wound Care Products
    • 2.2.6 Transmucosal Products
    • 2.2.7 Transdermal Products
  • 2.3 Drug-Devices Combination Market Structure
  • 2.4 Classification of Drug-Devices Combination Market

3. Drug-Device Combination Market: Global Market by End-Users 2017-2027

  • 3.1 Hospitals & Clinics Submarket Forecast & Analysis 2017-2027
  • 3.2 Emergency Service Centers Submarket Forecast & Analysis 2017-2027
  • 3.3 Ambulatory Surgical Centers Submarket Forecast & Analysis 2017-2027
  • 3.4 Home Care Settings Submarket Forecast & Analysis 2017-2027

4. Drug-Device Combination: Global Market by Products 2017-2027

  • 4.1 Drug Eluting Stents Submarket Forecast & Analysis 2017-2027
  • 4.2 Photosensitizers Submarket Forecast & Analysis 2017-2027
  • 4.3 Orthopedic Products Submarket Forecast & Analysis 2017-2027
  • 4.4 Infusion Pumps Submarket Forecast & Analysis 2017-2027
  • 4.5 Wound Care Products Submarket Forecast & Analysis 2017-2027
  • 4.6 Transmucosal Products Submarket Forecast & Analysis 2017-2027
  • 4.7 Transdermal Products Submarket Forecast & Analysis 2017-2027
  • 4.8 Other Combination Products Submarket Forecast & Analysis 2017-2027

5. Regional Drug-Device Combination Market Forecasts 2017-2027

  • 5.1 Regional Drug-Device Combination Market Forecasts 2017-2027
  • 5.2 North American Drug-Devices Combination Market Forecasts 2017-2027
    • 5.2.1 U.S. Drug-Devices Combination Market Forecasts 2017-2027
    • 5.2.2 Rest of North America Drug-Device Combination Market Forecasts 2017-2027
  • 5.3 North American Drug-Device Combination Market Forecasts by Products 2017-2027
  • 5.4 North American Drug-Device Combination Market Forecasts by End-Users 2017-2027
  • 5.5 Europe Drug-Device Combination Market Forecasts 2017-2027
    • 5.5.1 France Drug-Device Combination Market Forecasts 2017-2027
    • 5.5.2 Germany Drug-Device Combination Market Forecasts 2017-2027
    • 5.5.3 U.K. Drug-Device Combination Market Forecasts 2017-2027
    • 5.5.4 Spain Drug-Device Combination Market Forecasts 2017-2027
    • 5.5.5 Italy Drug-Device Combination Market Forecasts 2017-2027
    • 5.5.6 Russia Drug-Device Combination Market Forecasts 2017-2027
    • 5.5.7 Rest of Europe Drug-Device Combination Market Forecasts 2017-2027
  • 5.6 European Drug-Device Combination Market Forecasts by Products 2017-2027
  • 5.7 European Drug-Device Combination Market Forecasts by End-Users 2017-2027
  • 5.8 Asia-Pacific Drug-Device Combination Market Forecasts 2017-2027
    • 5.8.1 China Drug-Device Combination Market Forecasts 2017-2027
    • 5.8.2 India Drug-Device Combination Market Forecasts 2017-2027
    • 5.8.3 Japan Drug-Device Combination Market Forecasts 2017-2027
    • 5.8.4 Rest of Asia-Pacific (APAC) Drug-Device Combination Market Forecasts 2017-2027
  • 5.9 Asia-Pacific Drug-Device Combination Market Forecasts by Products 2017-2027
  • 5.10 Asia-Pacific Drug-Device Combination Market Forecasts by End-Users 2017-2027
  • 5.11 Rest of the World (RoW) Drug-Device Combination Market Forecasts 2017-2027
    • 5.11.1 Latin America Drug-Device Combination Market Forecasts 2017-2027
    • 5.11.2 Middle East and Africa Drug-Device Combination Market Forecasts 2017-2027
  • 5.12 Rest of the World (RoW) Drug-Device Combination Market Forecasts by Products 2017-2027
  • 5.13 Rest of the World (RoW) Drug-Device Combination Market Forecasts by End-Users 2017-2027

6. Drivers & Restraints

  • 6.1 Drivers and Restraints 2017-2027
  • 6.2 Drivers
    • 6.2.1 Increasing Initiatives by Government and NGO in Support of Drug Delivery Implants
    • 6.2.2 Rising popularity of minimally invasive surgeries
    • 6.2.3 Increasing Prevalence of Chronic Disorders
    • 6.2.4 Technological Innovations and Advancements
  • 6.3 Restraints
    • 6.3.1 Recall of Combination Products Due to Adverse Effects
    • 6.3.2 High Cost of Combination Products
    • 6.3.3 Regulatory and Technical Challenges Pertaining to Combination Products

7. Leading Companies in the Drug-Devices Combination Market

  • 7.1 Medtronic
    • 7.1.1 Medtronic Business Overview
    • 7.1.2 Medtronic Financial Overview
    • 7.1.3 Medtronic Product Portfolio
    • 7.1.4 Medtronic Corporate Strategy
  • 7.2 Boston Scientific Corporation
    • 7.2.1 Boston Scientific Corporation Business Overview
    • 7.2.2 Boston Scientific Corporation Financial Overview
    • 7.2.3 Boston Scientific Corporation Corporate Strategy
    • 7.2.4 Boston Scientific Corporation Product Portfolio
  • 7.3 Stryker Corporation
    • 7.3.1 Stryker Corporation Business Overview
    • 7.3.2 Stryker Corporation Financial Overview
    • 7.3.3 Stryker Corporation Product Portfolio
    • 7.3.4 Stryker Corporation Corporate Strategy
  • 7.4 Ethicon Inc.
    • 7.4.1 Ethicon Inc. Business Overview
    • 7.4.2 Ethicon Inc. Financial Overview
    • 7.4.3 Ethicon Inc. Corporate Strategy
    • 7.4.4 Ethicon Inc. Product Portfolio
  • 7.5 C. R. Bard Inc.
    • 7.5.1 C. R. Bard Inc. Business Overview
    • 7.5.2 C. R. Bard Inc. Financial Overview
    • 7.5.3 C.R. Bard Inc. Corporate Strategy
    • 7.5.4 C.R. Bard Inc. Product Portfolio
  • 7.6 Medline Industries Inc.
    • 7.6.1 Medline Industries Inc. Business Overview
    • 7.6.2 Medline Industries Inc. Financial Overview
    • 7.6.3 Medline Industries Inc. Corporate Strategy
  • 7.7 Mylan Inc.
    • 7.7.1 Mylan Inc. Business Overview
    • 7.7.2 Mylan Inc. Financial Overview
    • 7.7.3 Mylan Inc. Corporate Strategy
    • 7.7.4 Mylan Inc. Product Portfolio
  • 7.8 Terumo Corporation
    • 7.8.1 Terumo Corporation Business Overview
    • 7.8.2 Terumo Corporation Financial Overview
    • 7.8.3 Terumo Corporation Corporate Strategy
    • 7.8.4 Terumo Corporation Product Portfolio
  • 7.9 Pinnacle Biologics Inc.
    • 7.9.1 Pinnacle Biologics Inc. Business Overview
    • 7.9.2 Pinnacle Biologics Inc. Financial Overview
    • 7.9.3 Pinnacle Biologics Corporate Strategy
    • 7.9.4 Pinnacle Biologics Product Portfolio
  • 7.10 W.L. Gore & Associates Inc.
    • 7.10.1 W.L. Gore & Associates Inc. Business Overview
    • 7.10.2 W.L. Gore Associates & Inc. Financial Overview
    • 7.10.3 W.L. Gore Associates & Inc. Corporate Strategy
    • 7.10.4 W.L. Gore Associates & Inc. Product Portfolio

8. Qualitative Analysis of the Drug-Device Combination Market

  • 8.1 Porter's Five Forces Analysis of the Drug-Device Combination Market
  • 8.2 Rivalry among Competitors [High]
  • 8.3 Threat of New Entrants [Medium]
  • 8.4 Power of Suppliers [Low]
  • 8.5 Power of Buyers [Medium]
  • 8.6 Threat of Substitutes [Medium]

9. Conclusions

  • 9.1 Current Leading Drug-Device Combination Market Segments
    • 9.1.1 Leading Drug-Device Combination Products Companies
    • 9.1.2 Leading Regional Markets
    • 9.1.3 Emerging Drug-Device Combination Products Markets

Appendices

  • Associated Visiongain Reports
  • Visiongain Report Sales Order Form
  • Appendix A
  • About Visiongain
  • Appendix B
  • Visiongain report evaluation form

List of Figures

  • Figure 2.1 Global Drug-Devices Combination Market Segmentation Overview, 2017
  • Figure 3.1 Global Drug-Device Combination Market by End-Users, 2016, (% Share)
  • Figure 3.2 Drug-Device Combination Submarkets, by End-Users, Forecast ($bn) 2016-2027
  • Figure 3.3 Hospital and Clinics Market Forecasts, by % AGR 2017-2027
  • Figure 3.4 Global Hospitals & Clinics Market by Region, 2016-2027
  • Figure 3.5 Global Hospitals & Clinics Market Share, by Region, (% Share) 2016-2027
  • Figure 3.6 Emergency Service Centers Submarkets Forecasts, by % AGR 2017-2027
  • Figure 3.7 Global Emergency Service Centers Market by Region, 2016-2027
  • Figure 3.8 Global Emergency Service Centers Market Share, by Region, (% Share) 2016-2027
  • Figure 3.9 Ambulatory Surgical Centers Submarkets Forecasts, by % AGR 2017-2027
  • Figure 3.10 Global Physician Offices Market by Region, 2016-2027
  • Figure 3.11 Global Physician Offices Market Share, by Region, (% Share) 2016-2027
  • Figure 3.12 Home Care Settings Submarkets Forecasts, by % AGR 2017-2027
  • Figure 3.13 Global Home Care Settings Market by Region, 2016-2027
  • Figure 3.14 Global Home Care Settings Market Share, by Region, (% Share) 2016-2027
  • Figure 4.1 Global Drug-Device Combination Market by Products, 2016, (% Share)
  • Figure 4.2 Drug-Device Combination Submarkets, by Products Type, Forecast ($bn) 2016-2027
  • Figure 4.3 Drug Eluting Stent Market Forecasts, by % AGR 2017-2027
  • Figure 4.4 Global Drug Eluting Stent Market by Region, 2016-2027
  • Figure 4.5 Global Drug Eluting Stent Market Share, by Region, (% Share) 2016-2027
  • Figure 4.6 Photosensitizers Submarkets Forecasts, by % AGR 2017-2027
  • Figure 4.7 Global Photosensitizers Market by Region, 2016-2027
  • Figure 4.8 Global Photosensitizers Market Share, by Region, (% Share) 2016-2027
  • Figure 4.9 Orthopedic Products Submarkets Forecasts, by % AGR 2017-2027
  • Figure 4.10 Global Orthopedic Products Market by Region, 2016-2027
  • Figure 4.11 Global Orthopedic Products Market Share, by Region, (% Share) 2016-2027
  • Figure 4.12 Infusion Pumps Submarkets Forecasts, by % AGR 2017-2027
  • Figure 4.13 Global Infusion Pumps Market by Region, 2016-2027
  • Figure 4.14 Global Infusion Pumps Market Share, by Region, (% Share) 2016-2027
  • Figure 4.15 Wound Care Products Submarkets Forecasts, by % AGR 2017-2027
  • Figure 4.16 Global Wound Care Products Market by Region, 2016-2027
  • Figure 4.17 Global Wound Care Products Market Share, by Region, (% Share) 2016-2027
  • Figure 4.18 Transmucosal Products Submarkets Forecasts, by % AGR 2017-2027
  • Figure 4.19 Global Transmucosal Products Market by Region, 2016-2027
  • Figure 4.20 Global Transmucosal Products Market Share, by Region, (% Share) 2016-2027
  • Figure 4.21 Transdermal Products Submarkets Forecasts, by % AGR 2017-2027
  • Figure 4.22 Global Transdermal Products Market by Region, 2016-2027
  • Figure 4.23 Global Transdermal Products Market Share, by Region, (% Share) 2016-2027
  • Figure 4.24 Other Combination Products Submarkets Forecasts, by % AGR 2017-2027
  • Figure 4.25 Global Other Combination Products Market by Region, 2016-2027
  • Figure 4.26 Global Other Combination Products Market Share, by Region, (% Share) 2016-2027
  • Figure 5.1 Regional Drug-Device Combination Market Forecasts ($bn), 2017-2027
  • Figure 5.2 Regional Drug-Device Combination Market Share (%), 2016
  • Figure 5.3 North American Drug-Devices Combination Market Share Analysis, by Country ($bn, AGR%), 2016
  • Figure 5.4 U.S. Drug-Device Combination Market Forecasts ($bn), 2016-2027
  • Figure 5.5 Rest of North America Pharma Drug-Device Combination Market Forecasts ($bn), 2016-2027
  • Figure 5.6 North American Drug-Device Combination Market Revenue Analysis, by Product ($bn, AGR%), 2016-2027
  • Figure 5.7 North American Cancer Drug-Device Combination Market Revenue Analysis, by End-Users ($bn, AGR%), 2016-2027
  • Figure 5.8 European Pharma Clinical Trial Services Market Share Analysis, by Country ($bn, AGR%), 2016
  • Figure 5.9 France Drug-Device Combination Market Forecasts ($bn), 2016-2027
  • Figure 5.10 Germany Drug-Device Combination Market Forecasts ($bn), 2016-2027
  • Figure 5.11 U.K. Drug-Device Combination Market Forecasts ($bn), 2016-2027
  • Figure 5.12 Spain Pharma Clinical Trial Services Market Forecasts ($bn), 2016-2027
  • Figure 5.13 Italy Drug-Device Combination Market Forecasts ($bn), 2016-2027
  • Figure 5.14 Russia Drug-Device Combination Market Forecasts ($bn), 2016-2027
  • Figure 5.15 Rest of Europe Drug-Device Combination Market Forecasts ($bn), 2016-2027
  • Figure 5.16 European Drug-Device Combination Market Revenue Analysis, by Product ($bn, AGR%), 2016-2027
  • Figure 5.17 European Drug-Device Combination Market Revenue Analysis, by End-Users ($bn, AGR%), 2016-2027
  • Figure 5.18 Asia-Pacific Drug-Device Combination Market Share Analysis, by Country ($bn, AGR%), 2016
  • Figure 5.19 China Drug-Device Market Forecasts ($bn), 2016-2027
  • Figure 5.20 India Drug-Device Combination Market Forecasts ($bn), 2016-2027
  • Figure 5.21 Japan Drug-Device Combination Market Forecasts ($bn), 2016-2027
  • Figure 5.22 Rest of Asia-Pacific (APAC) Drug-Device Combination Market Forecasts ($bn), 2016-2027
  • Figure 5.23 Asia-Pacific Drug-Device Combination Market Revenue Analysis, by Products ($bn, AGR%), 2016-2027
  • Figure 5.24 Asia-Pacific Drug-Device Combination Market Revenue Analysis, by End-Users ($bn, AGR%), 2016-2027
  • Figure 5.25 Rest of the World (RoW) Drug-Device Combination Market Share Analysis, by Country ($bn, AGR%), 2016-2027
  • Figure 5.26 Latin America Drug-Device Combination Market Forecasts ($mn), 2016-2027
  • Figure 5.27 Middle East and Africa Drug-Device Combination Market Forecasts ($bn), 2016-2027
  • Figure 5.28 RoW Drug-Devices Combination Market Revenue Analysis, by Products ($bn, AGR%), 2016-2027
  • Figure 5.29 RoW Drug-Device Combination Market Revenue Analysis, by End-Users ($bn, AGR%), 2016-2027
  • Figure 6.1 Market: Drivers and Restraints, 2017-2027
  • Figure 7.1 Medtronic 2016 Annual Revenue by Business Segments
  • Figure 7.2 Medtronic Annual Revenue 2012- 2016 ($mn)
  • Figure 7.3 Boston Scientific Corporation 2016 Annual Revenue by Business Segments
  • Figure 7.4 Boston Scientific Corporation Annual Revenue 2012- 2016 ($mn)
  • Figure 7.5 Stryker Corporation 2016 Annual Revenue by Business Segments
  • Figure 7.6 Stryker Corporation Annual Revenue 2012- 2016 ($mn)
  • Figure 7.7 Johnson & Johnson 2016 Annual Revenue by Business Segments
  • Figure 7.8 Johnson & Johnson Annual Revenue 2012- 2016 ($mn)
  • Figure 7.9 C.R. Bard Inc. 2016 Annual Revenue by Business Segments
  • Figure 7.10 C. R. Bard Inc. Annual Revenue 2012- 2016 ($mn)
  • Figure 7.11 Mylan Inc. 2016 Annual Revenue by Business Segments
  • Figure 7.12 Mylan Inc. Annual Revenue 2012- 2016 ($mn)
  • Figure 7.13 Terumo Corporation 2016 Annual Revenue by Business Segments
  • Figure 7.14 Terumo Corporation Annual Revenue 2012- 2016 ($mn)
  • Figure 8.1 Porter's Five Forces Analysis of the Drug-Device Combination Market, 2017-2027

List of Tables

  • Table 3.1 Drug-Device Combination Products Submarkets, by End-Users Forecast ($bn, CAGR%)
  • Table 3.2 Hospitals/Clinical Laboratories Market, by Region, Forecast ($bn, AGR%, CAGR%) 2016-2027
  • Table 3.3 Emergency Service Centers Markets, by Region, Forecast ($bn, AGR%, CAGR%) 2016-2027
  • Table 3.4 Ambulatory Surgical Centers Markets, by Region, Forecast ($bn, AGR%, CAGR%) 2016-2027
  • Table 3.5 Home Care Settings markets, by Region, Forecast ($bn, AGR%, CAGR%) 2016-2027
  • Table 4.1 Drug-Device Combination Submarkets, by Products Type Forecast ($bn, CAGR%)
  • Table 4.2 Drug Eluting Stent Market, by Region, Forecast ($bn, AGR%, CAGR%) 2016-2027
  • Table 4.3 Photosensitizers Market, by Region, Forecast ($bn, AGR%, CAGR%) 2016-2027
  • Table 4.4 Orthopedic Products markets, by Region, Forecast ($bn, AGR%, CAGR%) 2016-2027
  • Table 4.5 Infusion Pumps Markets, by Region, Forecast ($bn, AGR%, CAGR%) 2016-2027
  • Table 4.6 Wound Care Products Market, by Region, Forecast ($bn, AGR%, CAGR%) 2016-2027
  • Table 4.7 Transmucosal Products Market, by Region, Forecast ($bn, AGR%, CAGR%) 2016-2027
  • Table 4.8 Transdermal Products Market, by Region, Forecast ($bn, AGR%, CAGR%) 2016-2027
  • Table 4.9 Other Combination Products Market, by Region, Forecast ($bn, AGR%, CAGR%) 2016-2027
  • Table 5.1 Regional Drug-Devices Combination Market Forecasts ($bn, AGR% CAGR%) 2016-2027
  • Table 5.2 U.S. Drug-Device Combination Market Forecasts ($bn, AGR% CAGR%) 2016-2027
  • Table 5.3 Rest of North America Drug-Device Combination Market Forecasts ($bn, AGR% CAGR%) 2016-2027
  • Table 5.4 North American Drug-Device Combination Market Forecasts, by Products Type ($bn, AGR% CAGR%) 2016-2027
  • Table 5.5 North American Drug-Device Combination Market Forecasts, by End-Users ($bn, AGR% CAGR%) 2016-2027
  • Table 5.6 France Drug-Device Combination Market Forecasts ($bn, AGR% CAGR%) 2016-2027
  • Table 5.7 Germany Drug-Device Combination Market Forecasts ($bn, AGR% CAGR%) 2016-2027
  • Table 5.8 U.K. Drug-Device Combination Market Forecasts ($bn, AGR% CAGR%) 2016-2027
  • Table 5.9 Spain Drug-Device Combination Market Forecasts ($bn, AGR% CAGR%) 2016-2027
  • Table 5.10 Italy Pharma Clinical Trial Services Market Forecasts ($bn, AGR% CAGR%) 2016-2027
  • Table 5.11 Russia Drug-Device Combination Market Forecasts ($bn, AGR% CAGR%) 2016-2027
  • Table 5.12 Rest of Europe Drug-Device Combination Market Forecasts ($bn, AGR% CAGR%) 2016-2027
  • Table 5.13 European Drug-Device Combination Market Forecasts, by Products ($bn, AGR% CAGR%) 2016-2027
  • Table 5.14 European Drug-Device Combination Market Forecasts, by End-Users ($bn, AGR% CAGR%) 2016-2027
  • Table 5.15 China Drug-Device Combination Market Forecasts ($bn, AGR% CAGR%) 2016-2027
  • Table 5.16 India Drug-Device Combination Market Forecasts ($bn, AGR% CAGR%) 2016-2027
  • Table 5.17 Japan Drug-Device Combination Market Forecasts ($bn, AGR% CAGR%) 2016-2027
  • Table 5.18 Rest of Asia-Pacific (APAC) Drug-Device Combination Market Forecasts ($bn, AGR% CAGR%) 2016-2027
  • Table 5.19 Asia-Pacific Drug-Device Combination Market Forecasts, by Products ($bn, AGR% CAGR%) 2016-2027
  • Table 5.20 Asia-Pacific Drug-Device Combination Market Forecasts, by End-Users ($bn, AGR% CAGR%) 2016-2027
  • Table 5.21 Latin America Drug-Device Combination Market Forecasts ($bn, AGR% CAGR%) 2016-2027
  • Table 5.22 Middle East and Africa Pharma Clinical Trial Services Market Forecasts ($bn, AGR% CAGR%) 2016-2027
  • Table 5.23 RoW Pharma Drug-Device Combination Market Forecasts, by Products ($bn, AGR% CAGR%) 2016-2027
  • Table 5.24 RoW Drug-Device Combination Market Forecasts, by Products ($bn, AGR% CAGR%) 2016-2027

Companies Listed

  • Bayer
  • Baxter Healthcare
  • Boehringer Ingelheim
  • Boston Scientific Corporation
  • C.R. Bard Inc.
  • CeloNova Biosciences
  • Center for Biologics Evaluation and Research (CBER)
  • Center for Devices and Radiological Health (CDRH)
  • Center for Drug Evaluation and Research (CDER)
  • Ethicon Inc
  • Johnson & Johnson Co.
  • Meda
  • Medline Industries Inc.
  • Medtronic
  • Menarini Group
  • Merck KGaA
  • Mylan Inc.
  • National Institute of Health and Care Excellence (NICE)
  • NeuWave Medical, Inc.
  • Orion Corporation
  • PhysioControl International, Inc.
  • Pinnacle Biologics Inc.
  • Sage Products, LLC
  • Stryker Corporation
  • Synergetics
  • Terumo Corporation
  • Unites States Food and Drug Administration (FDA)
  • ViaCyte, Inc.
  • W. L. Gore & Associates, Inc.
  • World Health Organization (WHO)
Back to Top